Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$0.89 - $2.36 $57 - $153
-65 Reduced 35.14%
120 $0
Q1 2024

May 01, 2024

BUY
$0.73 - $2.73 $62 - $232
85 Added 85.0%
185 $0
Q4 2023

Jan 25, 2024

BUY
$0.38 - $0.91 $38 - $91
100 New
100 $0
Q2 2023

Aug 11, 2023

BUY
$2.49 - $20.59 $869 - $7,185
349 Added 12.33%
3,179 $8,000
Q4 2022

Feb 02, 2023

SELL
$13.27 - $17.73 $477 - $638
-36 Reduced 1.26%
2,830 $45,000
Q3 2022

Nov 07, 2022

BUY
$11.4 - $14.6 $809 - $1,036
71 Added 2.54%
2,866 $47,000
Q2 2022

Aug 03, 2022

BUY
$7.94 - $12.96 $17,468 - $28,512
2,200 Added 369.75%
2,795 $30,000
Q1 2022

Apr 29, 2022

SELL
$12.02 - $16.79 $3,005 - $4,197
-250 Reduced 29.59%
595 $7,000
Q3 2021

Oct 18, 2021

SELL
$10.18 - $26.64 $45,810 - $119,880
-4,500 Reduced 84.19%
845 $9,000
Q2 2021

Aug 06, 2021

BUY
$18.57 - $35.68 $74,280 - $142,720
4,000 Added 297.4%
5,345 $142,000
Q1 2021

Apr 26, 2021

SELL
$31.0 - $55.72 $68,200 - $122,584
-2,200 Reduced 62.06%
1,345 $47,000
Q4 2020

Jan 25, 2021

BUY
$37.09 - $48.97 $25,963 - $34,279
700 Added 24.6%
3,545 $131,000
Q3 2020

Oct 20, 2020

BUY
$40.47 - $45.5 $14,933 - $16,789
369 Added 14.9%
2,845 $117,000
Q2 2020

Jul 27, 2020

BUY
$32.57 - $42.83 $13,874 - $18,245
426 Added 20.78%
2,476 $100,000
Q1 2020

Apr 17, 2020

SELL
$23.3 - $45.96 $3,961 - $7,813
-170 Reduced 7.66%
2,050 $71,000
Q4 2019

Jan 17, 2020

SELL
$34.58 - $48.06 $58,094 - $80,740
-1,680 Reduced 43.08%
2,220 $95,000
Q3 2019

Oct 17, 2019

BUY
$36.98 - $48.45 $126,841 - $166,183
3,430 Added 729.79%
3,900 $144,000
Q2 2019

Jul 12, 2019

BUY
$35.13 - $55.53 $4,918 - $7,774
140 Added 42.42%
470 $21,000
Q1 2019

Apr 17, 2019

SELL
$42.83 - $59.91 $250,298 - $350,114
-5,844 Reduced 94.66%
330 $18,000
Q3 2018

Oct 16, 2018

BUY
$56.3 - $67.25 $329,580 - $393,681
5,854 Added 1829.38%
6,174 $375,000
Q1 2018

Apr 10, 2018

SELL
$45.35 - $61.65 $13,605 - $18,495
-300 Reduced 48.39%
320 $15,000
Q3 2017

Oct 13, 2017

BUY
$33.4 - $53.9 $20,708 - $33,418
620
620 $33,000

Others Institutions Holding FGEN

About FIBROGEN INC


  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $32.8M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.